Research Progress of Macromolecules in the Prevention and Treatment of Sepsis
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Sepsis is associated with high rates of mortality in the intensive care unit and accompanied by systemic inflammatory reactions, secondary infections, and multiple organ failure. Biological macromolecules are drugs produced using modern biotechnology to prevent or treat diseases. Indeed, antithrombin, antimicrobial peptides, interleukins, antibodies, nucleic acids, and lentinan have been used to prevent and treat sepsis. In vitro, biological macromolecules can significantly ameliorate the inflammatory response, apoptosis, and multiple organ failure caused by sepsis. Several biological macromolecules have entered clinical trials. This review summarizes the sources, efficacy, mechanism of action, and research progress of macromolecular drugs used in the prevention and treatment of sepsis.
Tian T, Zhang N, Hu G, Lu R, Liu J Cent Eur J Immunol. 2024; 49(3):227-237.
PMID: 39720275 PMC: 11664811. DOI: 10.5114/ceji.2024.144199.
Su J, Tan Q, Wu S, Zhou F, Xu C, Zhao H Front Microbiol. 2024; 15:1452190.
PMID: 39282561 PMC: 11392888. DOI: 10.3389/fmicb.2024.1452190.
Inhibitory mechanisms of decoy receptor 3 in cecal ligation and puncture-induced sepsis.
Su J, Chen W, Zhou F, Li R, Tong Z, Wu S mBio. 2024; 15(6):e0052124.
PMID: 38700314 PMC: 11237498. DOI: 10.1128/mbio.00521-24.